Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: A double blind, placebo, controlled randomized clinical trial

Nutritional Neuroscience

Volumn 18, Issue 4, 2015, Pages 169-176

  Sanoobar, Meisam ^a,b   Eghtesadi, Shahryar ^a,b   Azimi, Amirreza ^c   Khalili, Mohammad ^a,b,d   Khodadadi, Behnam ^e   Jazayeri, Shima ^a,b   Gohari, Mahmood Reza ^f   Aryaeian, Nahid ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antioxidants; Coenzyme Q10; Cytokines; IL 6; Inflammation; MMP 9; Multiple sclerosis; Randomized placebo controlled trial; Supplementation; TGF ; TNF

Indexed keywords

GELATINASE B; INTERLEUKIN 4; INTERLEUKIN 6; LYMPHOTOXIN; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; UBIDECARENONE; BIOLOGICAL MARKER; MATRIX METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA; UBIQUINONE;

ADULT; ARTICLE; BLOOD ANALYSIS; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; INFLAMMATION; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH IRRITATION; SUPPLEMENTATION; ANALOGS AND DERIVATIVES; BLOOD; DIET SUPPLEMENTATION; DIET THERAPY; MIDDLE AGED;

ADULT; BIOLOGICAL MARKERS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-4; INTERLEUKIN-6; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; UBIQUINONE;

EID: 84927719564     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1179/1476830513Y.0000000106     Document Type: Article

References (42)

1. 1 Fernandes KS, Brum DG, Palei AC, Sandrim VC, Guerreiro CT, Tanus-Santos JE, et al. Functional MMP-9 polymorphisms modulate plasma MMP-9 levels in multiple sclerosis patients. J Neuroimmunol 2012;249(1-2):56-9.
2. 2 Furlan R, Bergami A, Lang R, Brambilla E, Franciotta D, Martinelli V, et al. Interferon-beta treatment in multiple sclerosis patients decreases the number of circulating T cells producing interferon-gamma and interleukin-4. J Neuroimmunol 2000; 111(1-2):86-92.
3. 3 van Horssen J, Witte ME, Schreibelt G, de Vries HE. Radical changes in multiple sclerosis pathogenesis. Biochim Biophys Acta (BBA)-Mol Basis Dis 2011;1812(2):141-50.
4. 4 Larochelle C, Alvarez JI, Prat A. How do immune cells overcome the blood-brain barrier in multiple sclerosis? FEBS Lett 2011;585(23):3770-80.
5. 5 Miller A, Shapiro S, Gershtein R, Kinarty A, Rawashdeh H, Honigman S, et al. Treatment of multiple sclerosis with copoly-mer-1 (Copaxone): implicating mechanisms of Th1 to Th2/Th3 immune-deviation. J Neuroimmunol 1998;92(1-2):113-21.
6. 6 Spooren A, Kolmus K, Laureys G, Clinckers R, De Keyser J, Haegeman G, et al. Interleukin-6, a mental cytokine. Brain Res Rev 2011;67(1):157-83.
7. 7 Choi HK, Pokharel YR, Lim SC, Han HK, Ryu CS, Kim SK, et al. Inhibition of liver fibrosis by solubilized coenzyme Q10: role of Nrf2 activation in inhibiting transforming growth factor-ß1 expression. Toxicol Appl Pharmacol 2009;240(3): 377-84.
8. 8 Dai YL, Luk TH, Yiu KH, Wang M, Yip P, Lee SWL, et al. Reversal of mitochondrial dysfunction by coenzyme Q10 supplement improves endothelial function in patients with ischaemic left ventricular systolic dysfunction: a randomized controlled trial. Atherosclerosis 2011;216(2):395-401.
9. 9 Lee BJ, Huang YC, Chen SJ, Lin PT. Effects of coenzyme Q10 supplementation on inflammatory markers (high-sensitivity C-reactive protein, interleukin-6, and homocysteine) in patients with coronary artery disease. Nutrition 2012;28(7-8):767-72.
10. 10 Kumar A, Kaur H, Devi P, Mohan V. Role of coenzyme Q10 (CoQ10) in cardiac disease, hypertension and Meniere-like syndrome. Pharmacol Therapeutics 2009;124(3):259-68.
11. 11 Fuller B, Smith D, Howerton A, Kern D. Anti-inflammatory effects of CoQ10 and colorless carotenoids. J Cosmet Dermatol 2006;5(1):30-8.
12. 12 Matthews RT, Yang L, Browne S, Baik M, Beal MF. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci 1998;95(15):8892-7.
13. 13 Schmelzer C, Lorenz G, Rimbach G, Döring F. In vitro effects of the reduced form of coenzyme Q10 on secretion levels of TNF-a and chemokines in response to LPS in the human monocytic cell line THP-1. J Clin Biochem Nutr 2009;44(1):62.
14. 14 Fouad AA, Jresat I. Hepatoprotective effect of coenzyme Q10 in rats with acetaminophen toxicity. Environ Toxicol Pharmacol 2012;33(2):158-67.
15. 15 Mancuso M, Orsucci D, Calsolaro V, Choub A, Siciliano G. Coenzyme Q10 and neurological diseases. Pharmaceuticals 2009;2(3):134-49.
16. 16 Bahar M, Khaghani S, Pasalar P, Paknejad M, Khorramizadeh MR, Mirmiranpour H, et al. Exogenous coenzyme Q10 modulates MMP-2 activity in MCF-7 cell line as a breast cancer cellular model. Nutr J 2010;9(62):1475-2891.
17. 17 Besler HIT, Comoglu SC, OkCu ZL Serum levels of antioxidant vitamins and lipid peroxidation in multiple sclerosis. Nutr Neurosci 2002;5(3):215-20.
18. 18 Jimenez-Jimenez FJ, Molina JA, de Bustos F, Garcia-Redondo A, Gomez-Escalonilla C, Martinez-Salio A, et al. Serum levels of coenzyme Q10 in patients with Parkinson's disease. J Neural Transm 2000;107(2):177-81.
19. 19 Sanoobar M, Eghtesadi S, Azimi A, Khalili M, Jazayeri S, Gohari MR. Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with relapsing-remitting multiple sclerosis. Int J Neurosci 2013; 123(11):776-82.
20. 20 Khalili M, Eghtesadi S, Mirshafiey A, Eskandari G, Sanoobar M, SahraianMA, et al. Effect oflipoic acid consumption onoxi-dative stress among multiple sclerosis patients: a randomized controlled clinical trial. Nutr Neurosci 2013;23485514.
21. 21 Khalili M, Izadi V, Eghtesadi S, Mirshafiey A, Sahraian MA, Motevalian A, et al. Is the lipoic acid consumption affect on the cytokine profile in the multiple sclerosis patients: a double blind, placebo, controlled randomized clinical trial. Neuroimmunomodulation 2013;DOI: 356145.
22. 22 McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50(1): 121-7.
23. 23 Lublin FD, Reingold SC. Defining the clinical course ofmultiple sclerosis results of an international survey. Neurology 1996;46(4): 907-11.
24. 24 Singh RB, Shinde SN, Chopra RK, Niaz MA, Thakur AS, Onouchi Z. Effect of coenzyme Q10 on experimental atherosclerosis and chemical composition and quality of atheroma in rabbits. Atherosclerosis 2000;148(2):275.
25. 25 Dhib-Jalbut S, Arnold DL, Cleveland DW, Fisher M, Friedlander RM, Mouradian MM, et al. Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases. J Neuroimmunol. 2006;176(1):198-215.
26. 26 Muzio L, Martino G, Furlan R. Multifaceted aspects of inflammation in multiple sclerosis: the role of microglia. J Neuroimmunol 2007;191(1):39-44.
27. 27 Silber E, Sharief MK. Axonal degeneration in the pathogenesis of multiple sclerosis. J Neurol Sci 1999;170(1):11-18.
28. 28 Bessler H, Bergman M, Blumberger N, Djaldetti M, Salman H. Coenzyme Q10 secreases TNF-ALPHA. and IL-2 secretion by human peripheral blood mononuclear cells. J Nutr Sci Vitaminol 2010;56(1):77-81.
29. 29 Carmona MC, Lefebvre P, Lefebvre B, Galinier A, Bénani A, Jeanson Y, et al. Coadministration of coenzyme Q prevents rosi-glitazone-induced adipogenesis in ob/ob mice. Int J Obes 2009; 33(2):204-11.
30. 30 Fouad AA, Al-Sultan AI, Refaie SM, Yacoubi MT. Coenzyme Q10 treatment ameliorates acute cisplatin nephrotoxicity in mice. Toxicology 2010;274(1):49-56.
31. 31 Martino G, Furlan R, Brambilla E, Bergami A, Ruffini F, Gironi M, et al. Cytokines and immunity in multiple sclerosis: the dual signal hypothesis. J Neuroimmunol 2000; 109(1):3-9.
32. 32 Sohet FM, Neyrinck AM, Pachikian BD, de Backer FC, Bindels LB, Niklowitz P, et al. Coenzyme Q10 supplementation lowers hepatic oxidative stress and inflammation associated with diet-induced obesity in mice. Biochem Pharmacol 2009;78(11): 1391-400.
33. 33 Inui M, Ooe M, Fujii K, Matsunaka H, Yoshida M, Ichihashi M. Mechanisms of inhibitory effects of CoQ10 on UVB-induced wrinkle formation in vitro and in vivo. Biofactors 2008;32(1-4):237-43.
34. 34 Premkumar VG, Yuvaraj S, Sathish S, Shanthi P, Sachdanandam P. Anti-angiogenic potential of Coenzyme Q10, riboflavin and niacin in breast cancer patients undergoing tamoxifen therapy. Vase Pharmacol 2008;48(4): 191-201.
35. 35 Gokbel H, Gergerlioglu HS, Okudan N, Gul I, Buyukbas S, Belviranli M. Effects of coenzyme Q10 supplementation on plasma adiponeetin, interleukin-6, and tumor necrosis factor-alpha levels in men. J Med Food 2010;13(1):216-18.
36. 36 Imitola J, Chitnis T, Khoury SJ. Cytokines in multiple sclerosis: from bench to bedside. Pharmacol Therapeutics 2005;106(2): 163-77.
37. 37 Meoli EM, Oh U, Grant CW, Jacobson S. TGF-beta signaling is altered in the peripheral blood of subjects with multiple sclerosis. J Neuroimmunol 2011;230(1-2):164-8.
38. 38 Losy J, Michalowska-Wender G. In vivo effect of interferon-ß 1a on interleukin-12 and TGF-ß1 cytokines in patients with relap-sing-remitting multiple sclerosis. Acta Neurol Scand 2002; 106(1):44-6.
39. 39 Kandhare AD, Ghosh P, Ghule AE, Bodhankar SL. Elucidation of molecular mechanism involved in neuroprotective effect of Coenzyme Q10 in alcohol-induced neuropathic pain. Fundam Clin Pharmacol 2013;27(6):603-22.
40. 40 Hohnoki K, Inoue A, Koh CS. Elevated serum levels of IFN-gamma, IL-4 and TNF-alpha/unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage. J Neuroimmunol 1998;87(1-2):27-32.
41. 41 Yubero-Serrano EM, Gonzalez-Guardia L, Rangel-Zuniga O, Delgado-Lista J, Gutierrez-Mariscal FM, Perez-Martinez P, et al. Mediterranean diet supplemented with coenzyme Q10 modifies the expression of proinflammatory and endoplasmic reticulum stress-related genes in elderly men and women. J Gerontol A Biol Sci Med Sci 2012;67(1):3-10.
42. 42 Leppert D, Lindberg RL, Kappos L, Leib SL. Matrix metallo-proteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Res Brain Res Rev 2001;36(2-3):249-57.